Non-marketable Equity Securities	9 Months Ended
Non-marketable Equity Securities	Sep. 30, 2013
Investments, All Other Investments [Abstract]
Non-marketable Equity Securities	Non-marketable Equity Securities The aggregate cost of the Company's cost method investments totaled $5,952,123 at September 30, 2013 and $6,706,012 at December 31, 2012. Cost method investments at September 30, 2013 include $5,273,000 in Federal Home Loan Bank ("FHLB") stock and $679,123 of investments in various trust and financial companies, which are included in other assets. All cost method investments were evaluated for impairment at September 30, 2013 and December 31, 2012. The following factors have been considered in determining the carrying amount of FHLB stock: 1) the recoverability of the par value, 2) the Company has sufficient liquidity to meet all operational needs in the foreseeable future and would not need to dispose of the stock below recorded amounts, 3) redemptions and purchases of the stock are at the discretion of the FHLB, 4) the Company believes the FHLB has the ability to absorb economic losses given the expectation that the various FHLBs' have a high degree of government support, and 5) the unrealized losses related to securities owned by the FHLB are manageable given the capital levels of the organization. During the nine months ended September 30, 2013, the Company's investment in a financial services company was considered to be other than temporarily impaired and approximately $39,185 was charged-off. The remaining value of the investment after the charge-off was $62,815 at September 30, 2013. There were no other than temporary impairments recorded for the three months ended September 30, 2013. There were no other than temporary impairments recorded for the three and nine months ended September 30, 2012.

The entire disclosure for investments accounted for under the cost-method. The carrying amount of such investments may be adjusted, for example, distributions in excess of cost (return of capital) or for other-than-temporary impairments. The cost method and lower-of-cost or market, an adaptation of the cost method, is generally followed for most investments in noncontrolled corporations, in some corporate joint ventures, and to a lesser extent in unconsolidated subsidiaries in which the entity does not have the ability to exercise significant influence.

+ References+ Details